1.32 (-%)
As of Nov 12, 2024
Source:
Protalix Biotherapeutics, Inc. is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by our proprietary ProCellEx® plant cell-based protein expression system. We are the first and only company to gain FDA approval of a protein produced through plant cell-based expression in suspension.
Country | United States |
Headquarters | hackensack, new jersey |
Phone Number | 201-696-9345 |
Industry | manufacturing |
CEO | Dror Bashan |
Website | http://www.protalix.com |